• Stellar start to the year – Q1 FY9/26 results saw MRI record OP surging 133.5% YoY and RP rising 99.0% YoY, driven by healthy top-line growth and minimal incremental costs. GPM reached 27.3%, and OPM climbed to 11.2%. Earnings visibility is high, as the sum of Q1 FY9/26 net sales and order backlog already accounts for 74.4% of FY net sales guidance. The TTC segment remains the cornerstone of the group’s growth trajectory, particularly through strong momentum in the government and public offices sector. FY9/26 is positioned as a year of business rebuild, with key initiatives to expand the concentration domains in TTC (electric power and energy, medical and long-term care, business analytics and AI) and the growth area in ITS (public and electric power, HR and education, financial, DA and AI).
13 Feb 2026
Mitsubishi Research Institute (3636) Q1 FY9/26 results update: Exceptionally strong Q1, while FY guidance intact
Mitsubishi Research Institute (3636:TKS), 0 | Fujitsu Limited (6702:TKS), 0 | NTT Data Intramart Corporation (3850:TKS), 0 | NEC Corporation (6701:TKS), 0 | OTSUKA CORPORATION (4768:TKS), 0 | Nomura Research Institute,Ltd. (4307:TKS), 0 | BIPROGY Inc. (8056:TKS), 0 | Oracle Corporation Japan (4716:TKS), 0 | DENTSU SOKEN INC. (4812:TKS), 0 | NS Solutions Corp (2327:TKS), 0 | International Business Machines Corporation (IBM:NYS), 0 | Accenture (ACN:NYSE), 0 | Capgemini (CAP:EPA), 0 | Leidos Holdings, Inc. (LDOS:NYS), 0 | Science Applications International (SAIC:NYSE), 0 | CACI International (CACI:NYSE), 0 | EPAM Systems (EPAM:NYSE), 0 | FTI Consulting, Inc. (FCN:NYS), 0 | Globant (GLOB:NYSE), 0 | CGI Inc. Class A (0A18:LON), 7,635
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Mitsubishi Research Institute (3636) Q1 FY9/26 results update: Exceptionally strong Q1, while FY guidance intact
Mitsubishi Research Institute (3636:TKS), 0 | Fujitsu Limited (6702:TKS), 0 | NTT Data Intramart Corporation (3850:TKS), 0 | NEC Corporation (6701:TKS), 0 | OTSUKA CORPORATION (4768:TKS), 0 | Nomura Research Institute,Ltd. (4307:TKS), 0 | BIPROGY Inc. (8056:TKS), 0 | Oracle Corporation Japan (4716:TKS), 0 | DENTSU SOKEN INC. (4812:TKS), 0 | NS Solutions Corp (2327:TKS), 0 | International Business Machines Corporation (IBM:NYS), 0 | Accenture (ACN:NYSE), 0 | Capgemini (CAP:EPA), 0 | Leidos Holdings, Inc. (LDOS:NYS), 0 | Science Applications International (SAIC:NYSE), 0 | CACI International (CACI:NYSE), 0 | EPAM Systems (EPAM:NYSE), 0 | FTI Consulting, Inc. (FCN:NYS), 0 | Globant (GLOB:NYSE), 0 | CGI Inc. Class A (0A18:LON), 7,635
- Published:
13 Feb 2026 - Author:
-
Pages:
14 -
• Stellar start to the year – Q1 FY9/26 results saw MRI record OP surging 133.5% YoY and RP rising 99.0% YoY, driven by healthy top-line growth and minimal incremental costs. GPM reached 27.3%, and OPM climbed to 11.2%. Earnings visibility is high, as the sum of Q1 FY9/26 net sales and order backlog already accounts for 74.4% of FY net sales guidance. The TTC segment remains the cornerstone of the group’s growth trajectory, particularly through strong momentum in the government and public offices sector. FY9/26 is positioned as a year of business rebuild, with key initiatives to expand the concentration domains in TTC (electric power and energy, medical and long-term care, business analytics and AI) and the growth area in ITS (public and electric power, HR and education, financial, DA and AI).